Search results
Earnings call: Atea Pharmaceuticals reports progress in COVID-19 trial By Investing.com
Investing.com· 16 hours agoThe company reported the completion of patient enrollment ahead of schedule for its SUNRISE-3 global...
Wearing face masks did not reduce risk of COVID infection after first omicron wave, research...
Medical Xpress· 7 hours agoNew research from the University of East Anglia has found that wearing face masks did not lower the...
Week in Review: Northern Lights visible in Chicago • New COVID variants spreading • Missing man...
FOX News Chicago· 3 days agoThe Northern Lights were visible in Chicago Friday night amid a historic geomagnetic storm; a new...
Covid subvariants leading infections | Arkansas Democrat Gazette
Arkansas Democrat-Gazette· 4 days agoTwo new covid-19 subvariants, collectively nicknamed FLiRT, are increasingly edging out the winter's...
What is 'FLiRT' COVID? Scientists predict spike of new coronavirus variants
WJLA· 5 days agoThe variants, known as “FLiRT,” are distinguished by mutations in the disease’s spike proteins....
Daywatch: COVID ‘FLiRT’ variants are spreading
Chicago Tribune· 7 days agoA new family of COVID variants nicknamed “FLiRT” is spreading across the country, as vaccination rates in Chicago — as well as nationwide — remain...
New COVID mutations called FLIRT detected in Las Vegas valley
KTNV Las Vegas· 5 days agoCOVID-19 is still a concern nationwide. Scientists have nicknamed the new variants FLIRT after their mutations. "I haven't had a COVID ...
Feldman: COVID isn't done with us yet
Gannett via AOL· 16 hours agoThere’s an expression: “You may be done with COVID, but COVID isn’t done with you.” It’s true. COVID-19 is still very much with us even though we would ...
Axios Vitals
Axios· 7 days agoTo most Americans, COVID-19 now ranks with everyday risks like reckless driving, smoking and drinking too much. Why it matters: As much as the public...
Earnings call: Atea Pharmaceuticals reports progress in COVID-19 trial
Investing.com· 20 hours agoThe company reported the completion of patient enrollment ahead of schedule for its SUNRISE-3 global...
